
Astal Laboratories Ltd Valuation Shifts to Very Attractive Amid Mixed Returns
2026-11-17 08:00:11Astal Laboratories Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive price level, driven primarily by a notable decline in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This recalibration of valuation metrics invites a closer examination of the company’s price attractiveness relative to its historical averages and peer group within the Trading & Distributors sector.
Read More
Astal Laboratories Ltd Falls to 52-Week Low of Rs 50.55 as Sell-Off Deepens
2026-11-03 14:10:18A 45.18% decline over the past year has culminated in Astal Laboratories Ltd hitting a fresh 52-week low of Rs 50.55 on 3 Nov 2026, despite the broader market rallying with the Sensex up 1.26% on the same day.
Read More
Five Consecutive Losses Push Astal Laboratories Ltd to a New 52-Week Low
2026-10-30 15:37:47For the fifth straight session, Astal Laboratories Ltd closed lower, breaching its 52-week low territory at Rs 60.45 on 30 Oct 2026. This persistent decline has dragged the stock down by 8.72% over the last three days alone, underperforming its sector which gained 2.24% on the same day.
Read More
Astal Laboratories Ltd is Rated Hold
2026-10-16 10:10:03Astal Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read MoreAstal Laboratories Declines 4.39%: 2 Key Factors Driving the Weekly Downtrend
2026-10-11 15:00:35Key Events This Week Oct 5: Valuation shifts signal changing market perception Oct 9: Formation of Death Cross signals potential bearish trend Oct 9: Week closes at Rs.68.14 (-4.39%) Week OpenRs.71.27 Week CloseRs.68.14-4.39% <div class="stat-l...
Read More
Astal Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend
2026-10-09 18:00:12Astal Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s medium to long-term outlook.
Read More
Astal Laboratories Ltd is Rated Hold
2026-10-05 10:10:03Astal Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 October 2026, providing investors with the most up-to-date insight into the stock’s fundamentals and market performance.
Read More
Astal Laboratories Ltd Valuation Shifts Signal Changing Market Perception
2026-10-05 08:00:14Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. Despite recent share price declines and underperformance relative to the Sensex, the stock’s improved price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more compelling entry point for investors seeking value in a challenging market environment.
Read More
Astal Laboratories Ltd is Rated Hold
2026-09-24 10:10:27Astal Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
17-Nov-2026 | Source : BSESubmission of newspaper publication of Quarterly results.
Results- Financial Results For September 30 2026.
13-Nov-2026 | Source : BSESubmission of Financial Results.
Compliances- Statement Of Deviation & Variation
13-Nov-2026 | Source : BSESubmission of statement of Deviation and variation for September 2026 quarter.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available